Download
1 / 4
40 likes | 301 Views
No Relevant Financial Relationships with Commercial Interest. JoAnn Mason, MD, MPH, DrPH – How Much is Enough: How Much is Too Much?. Disclosures. Dr. JoAnn Manson has no real or apparent conflicts of interest related to this presentation.
E N D
No Relevant Financial Relationships with Commercial Interest JoAnn Mason, MD, MPH, DrPH – How Much is Enough: How Much is Too Much? Disclosures Dr. JoAnn Manson has no real or apparent conflicts of interest related to this presentation. Dr. Manson and colleagues have received funding from the NIH (NCI, NHLBI, NINDS, NCCAM, ODS) to conduct a large-scale randomized trial of vitamin D in the prevention of cancer and CVD (VITAL). Other NIH institutes support VITAL ancillary studies. Dr. Manson was a member of the IOM Committee on DRIs for vitamin D and calcium (2011).
No Relevant Financial Relationships with Commercial Interest Donald L. Trump, MD, FACP – Does Vitamin D Inhibit Cancer? How Strong is the Clinical Evidence? Disclosures
No Relevant Financial Relationships with Commercial Interest James Fleet, PhD – Potential Mechanisms for Vitamin D-Mediated Effects on Cancer Disclosures
Johanna Lampe PhD, RD is a Principal Investigator for Otsuka PharmaceuticalNo other planners report any financial relationships of commercial interests The Frontiers in Nutrition and Cancer Prevention Planning and Steering Committee: Gabriela Riscuta MD, CNS, John A. Milner, PhD, Elaine Trujillo, MS, RD, Rhonda Wilt DeJoice, Kara Smigel Croker, Steven K. Clinton, MD, PhD, Omer Kucuk, MD, Johanna Lampe PhD, RD, Scott Lipmann, MD, Susan Mayne, PhD and Sylvia Rowe, MA Disclosures
